Reference number : 172-2022-2023-Q3-997959, amendment number : , agreement type : C, recipient legal name : Kane Biotech Inc., recipient country : CA, recipient province : MB, recipient city : Winnipeg|Winnipeg, recipient postal code : R3T 6G2, program name english : Industrial Research Assistance Program – Contributions to Firms, program name french : Programme d’aide à la recherche industrielle – Contributions aux entreprises, program purpose english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, program purpose french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, agreement title english : Development of Commercial Scale DispersinB® Production Method, agreement title french : Développement d’une méthode de production de DispersinB® à l’échelle commerciale, agreement number : 997959, agreement value : 74490.0, agreement start date : 2022-11-15, agreement end date : 2023-05-15, description english : To develop a cost-effective fermentation and purification manufacturing process for DispersinB®, description french : Développer un procédé de fermentation et de purification rentable pour la fabrication de DispersinB®., expected results english : The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization, expected results french : Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation, additional information english : nan, additional information french : nan, owner organization : nrc-cnrc, owner organization title : National Research Council Canada | Conseil national de recherches Canada